#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Complex regional pain syndrome High-grade B-cell lymphoma Duchenne muscular dystrophy Raynaud's phenomenon X-linked lymphoproliferative syndrome Alveolar proteinosis Frontotemporal dementia Microscopic polyangiitis Cystic fibrosis respiratory infection suppression Acromegaly Herpes simplex Biliary cancer metastatic Anaplastic large cell lymphoma T- and null-cell types Marginal zone lymphoma refractory Osteochondrodysplasia More trials…

    Learn about Rare Diseases

    Pulmonary fibrosis – Basic Information Leiomyosarcoma metastatic – Treatment Castleman’s disease – Treatment Mucopolysaccharidosis I – Diagnostics Chondrosarcoma metastatic – Trials in Disease Undifferentiated sarcoma – Basic Information Tuberous sclerosis complex – Treatment Inclusion body myositis – Life with Disease Alexander disease – Life with Disease Niemann-Pick disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Aaa802 Aspergillus Fumigatus Gsk4011499 Levothyroxine Cinnarizine Tralokinumab Venlafaxine Oxaliplatin Ozanimod Tng462 VX-407 Alxn1850 Ocrelizumab Interleukin-2 Betula Verrucosa (108) Vafidemstat Pegipanermin Sodium Phosphate Temsirolimus Ucart22 More therapies…

    Learn about Your Condition

    Corneal graft failure Hepatobiliary disease Hernia repair Vascular dementia Supraventricular tachycardia Bronchitis Anxiety disorder Hypersomnia Immune-mediated enterocolitis Obstructive pancreatitis Chronic myeloid leukaemia Obliterative bronchiolitis Marfan's syndrome Craniotomy Colour blindness More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dementia Alzheimer’s type

  • Study on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Mirodenafil Dihydrochloride
    Czechia Denmark France Germany Italy The Netherlands +2

  • Study on AVP-786 for Treating Agitation in Alzheimer’s Dementia Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Deudextromethorphan Hydrobromide
    • Quinidine Sulfate
    Belgium Croatia Hungary Ireland The Netherlands Slovakia +2

  • Study on the Effects of GV1001 for Patients with Mild to Moderate Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Tertomotide
    Finland France Italy The Netherlands Poland Portugal +1

  • Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer’s Dementia Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Deudextromethorphan Hydrobromide
    • Quinidine Sulfate
    Bulgaria Denmark Estonia Germany Greece Poland +1

  • Study of ACP-204 for Treating Psychosis in Adults with Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy Spain

  • Study of BAN2401 (lecanemab) in people with early stage Alzheimer’s disease to evaluate its effectiveness in preventing disease progression

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Flutafuranol (18F)
    • Lecanemab
    • Florquinitau (18F)
    Spain
Previous Page
1 … 11 12 13 14 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!